Literature DB >> 15101678

JNMA points to the need of more drug metabolism studies on black patients.

Michael D Floyd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15101678      PMCID： PMC2595015     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  5 in total

1.  Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells.

Authors:  E G Schuetz; W T Beck; J D Schuetz
Journal:  Mol Pharmacol       Date:  1996-02       Impact factor: 4.436

2.  Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women.

Authors:  Michael D Floyd; Guillermo Gervasini; Andrew L Masica; Gail Mayo; Alfred L George; Kolari Bhat; Richard B Kim; Grant R Wilkinson
Journal:  Pharmacogenetics       Date:  2003-10

Review 3.  Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Authors:  Zeruesenay Desta; Xiaojiong Zhao; Jae-Gook Shin; David A Flockhart
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

4.  CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects.

Authors:  Yoshihiko Soga; Fusanori Nishimura; Yoko Ohtsuka; Hiroaki Araki; Yoshihiro Iwamoto; Hisa Naruishi; Nobuyuki Shiomi; Yoshitomo Kobayashi; Shogo Takashiba; Kenji Shimizu; Yutaka Gomita; Eiji Oka
Journal:  Life Sci       Date:  2004-01-02       Impact factor: 5.037

Review 5.  Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.

Authors:  U I Schwarz
Journal:  Eur J Clin Invest       Date:  2003-11       Impact factor: 4.686
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.